Spots Global Cancer Trial Database for RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours
Official Title: A Phase I/II Study of RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours
Study ID: NCT03199872
Conditions
Interventions
Study Description
Brief Summary: The study will evaluate safety and immunological response to RhoC peptide vaccine in patients with prostate cancer
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Rigshospitalet, Copenhagen, , Denmark
Contact Details
Name: Jesper Sonne, MD, PhD
Affiliation: Dantrials Aps
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
